Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 31 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

10%

3 trials in Phase 3/4

Results Transparency

31%

4 of 13 completed with results

Key Signals

4 with results100% success

Data Visualizations

Phase Distribution

22Total
Not Applicable (14)
Early P 1 (1)
P 1 (4)
P 3 (1)
P 4 (2)

Trial Status

Completed13
Recruiting6
Unknown6
Not Yet Recruiting2
Withdrawn2
Active Not Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 13 completed trials

Clinical Trials (31)

Showing 20 of 20 trials
NCT04862273Completed

CMR T1 Mapping for Diagnosis of Cardiac Amyloidosis

NCT05647213Phase 1Recruiting

Autologous Induced Pluripotent Stem Cells of Cardiac Lineage for Congenital Heart Disease

NCT06791850Not ApplicableRecruiting

Sustaining Home Heart Failure Palliative Care in Rural Appalachia

NCT04237701Recruiting

Real-Time Monitoring of Heart Failure Across the Yale New Haven Health System

NCT03387813Not ApplicableCompleted

Hemodynamic-GUIDEd Management of Heart Failure

NCT07099495Not ApplicableNot Yet Recruiting

REDUCED FUNCTIONALITY AND KINESIOPHOBIA IN PATIENTS WITH HEART FAILURE: USE OF ALTERNATIVE THERAPEUTIC STRATEGIES

NCT07045649Recruiting

Association Between the Sit-To-Stand Test and the Prognosis of Patients With Heart Failure

NCT04180696Not ApplicableCompleted

Mid-Q Response Study

NCT05835063Not ApplicableCompleted

A Study to Improve Physician-Youth Communication and Medical Decision Making

NCT06299176Phase 1Enrolling By Invitation

Whole Heart Radiotherapy for End-stage Heart Failure

NCT04528004Early Phase 1Active Not Recruiting

Mechanistic Studies of Nicotinamide Riboside in Human Heart Failure

NCT06641284Completed

Gender-Based Differences in Heart Failure Hospitalizations Among Patients With Heart Failure Treated With Spironolactone

NCT05575336Not ApplicableCompleted

Assessment of the Effectiveness, Socio-economic Impact and Implementation of a Digital Solution for Severe Patients

NCT04153890Not ApplicableCompleted

Family Palliative and End-of-Life Care for Advanced Heart Failure

NCT03631654Phase 4WithdrawnPrimary

Ivabradine in Stage D Heart Failure Patients on Chronic Inotropes

NCT06097481Phase 1Not Yet Recruiting

Narrative Intervention for Chronic Illness- Heart Failure Trial (NICI-HF)

NCT05632432Not ApplicableRecruiting

Atrial Appendage Micrograft Transplants to Assist Heart Repair After Cardiac Surgery

NCT06233695Completed

Gender-based Differences in the Outcome of Treatment With Aldosterone Antagonists in Patients With Heart Failure

NCT03580759Not ApplicableCompleted

Exergaming in Advanced HF With Multiple Chronic Conditions Prior to LVAD Implantation or Heart Transplant

NCT05487365Not ApplicableUnknown

Implementation and Cost-evaluation of a Smartphone-based Telemonitoring and Digital Support in Patients With HF

Scroll to load more

Research Network

Activity Timeline